ArticleMolecular biology reports2026
miR-1-3p downregulation drives tumor invasion in oral squamous cell carcinoma: insights from in vitro, in vivo, and ex vivo models.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimOral squamous cell carcinoma (OSCC) often presents as an invasive tumor with poor prognosis. Recent evidence suggests that microRNAs, particularly miR-1-3p, may regulate the molecular pathways associated with tumor invasion. This study aimed to investigate the functional role of miR-1-3p in OSCC invasion using integrated in vitro, in vivo, and ex vivo approaches, and to evaluate its expression in tumors with varying depths of invasion (DOI).
methodsSCC-9 cells were transfected with miR-1-3p mimic and inhibitor. Invasion was assessed using transwell assays. Zebrafish xenografts were generated to evaluate tumor area, invasion depth, migration, and metastasis. Additionally, miR-1-3p expression was quantified by RT-qPCR in 26 human OSCC samples stratified by different groups of DOI.
resultsmiR-1-3p inhibition significantly increased tumor cell invasion in vitro (P = 0.039) and resulted in larger, deeper, and more migratory tumors in vivo (P < 0.05). All in vitro experiments were performed in duplicate, which may limit the precision of quantitative estimates. Metastases were observed in 30.8% of larvae injected with miR-1-3p-inhibited cells, representing a trend toward increased metastatic behavior (P = 0.052). In human samples, miR-1-3p expression was significantly negatively correlated with DOI (Spearman's R = - 0.435; P = 0.030), and deeply invasive tumors exhibited lower expression levels (P = 0.040).
conclusionThis integrative analysis supports an association between miR-1-3p downregulation and increased invasive tumor behavior in OSCC across experimental models and human tumor samples. These findings provide preliminary translational evidence and support further investigation into the potential role of miR-1-3p as a biomarker in OSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.